Virax Biolabs Group Limited Ordinary Shares

VRAX•United States

Healthcare United States In Vitro & In Vivo Diagnostic Substances

Need professional-grade analysis? Visit stockanalysis.com

$0.18

+2.72%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	-1.37	-1.38	-1.40	—	-1.39
Calmar	—	—	-1.60	-1.24	-1.00	—	-1.23
Sharpe	—	—	-1.06	-0.68	-0.78	—	-0.82
Omega	—	—	0.60	0.69	0.74	—	0.69
Martin	—	—	-2.45	-2.03	-1.61	—	-1.96
Ulcer	—	—	38.37	45.70	53.61	—	47.16

Virax Biolabs Group Limited Ordinary Shares (VRAX) Price Performance

Virax Biolabs Group Limited Ordinary Shares (VRAX) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $0.18, up 2.72% from the previous close.

Over the past year, VRAX has traded between a low of $0.17 and a high of $1.27. The stock has lost 86.0% over this period. It is currently 86.0% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: N/A

Technical Indicators

52 Week High: $1.35
52 Week Low: $0.17
50 Day MA: $0.26
200 Day MA: $0.57
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A